3Du Y, Dodel R, Hempal H,et al.Reduced levels of amyloid β-peptide antibody in Alzheimer disease [J]. Neurology,2001,57(3):801-805.
4Giovanni A,Keramaris E,Morris EJ,et al.E2F1 mediates death of β-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and Caspase 3[J]. J Biol Chem,2000,275(16):11553-11560.
5Svendsen CN. Survival and differentiation of rat and human epidermal growth factor-responsive precursor cells following grafting into the lesioned adult central nervous systen[J].Exp Neurol,1996,137(2):376-388.
6Reiriz J, Espejo M,Ventura F,et al. Bone morphogenetic protein 2 promotes dissociated effects on the number and diffentiation of cultured ventral mesencephalic dopaminergic neurons [J]. Neurobiololgy, 1999, 38 (2):161-170.
7Citron M. β-secretase inhibition for the treatment of Alzheimer′s disease-promise and challenge[J].Trends Pharmacol Sci, 2004, 25(2):92-97.
8Fassbender K, Masters C, Beyreuther K. Alzheimer′s disease: an inflammatory disease[J]?Neurobiol Aging,2000,21(2):433-436.
9Selkoe DJ. Deciphering the genesis and fate of amyloid β-protein yields novel therapies for Alzheimer disease[J]. J Clin Invest,2002,110:1375-1381.
